"Patient Selection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Criteria and standards used for the determination of the appropriateness of the inclusion of patients with specific conditions in proposed treatment plans and the criteria used for the inclusion of subjects in various clinical trials and other research protocols.
Descriptor ID |
D018579
|
MeSH Number(s) |
E05.581.500.653 N04.590.731
|
Concept/Terms |
Patient Selection- Patient Selection
- Patient Selections
- Selection, Patient
- Selections, Patient
Research Subject Recruitment- Research Subject Recruitment
- Recruitment, Research Subject
- Recruitments, Research Subject
- Research Subject Recruitments
- Subject Recruitment, Research
- Subject Recruitments, Research
Research Subject Selection- Research Subject Selection
- Research Subject Selections
- Selection, Research Subject
- Selections, Research Subject
- Subject Selection, Research
- Subject Selections, Research
Selection for Treatment- Selection for Treatment
- Selection for Treatments
- Treatment, Selection for
- Treatments, Selection for
Patient Recruitment- Patient Recruitment
- Patient Recruitments
- Recruitment, Patient
- Recruitments, Patient
|
Below are MeSH descriptors whose meaning is more general than "Patient Selection".
Below are MeSH descriptors whose meaning is more specific than "Patient Selection".
This graph shows the total number of publications written about "Patient Selection" by people in this website by year, and whether "Patient Selection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2010 | 1 | 0 | 1 |
2013 | 0 | 1 | 1 |
2016 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 0 | 2 | 2 |
2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Patient Selection" by people in Profiles.
-
Heregulin (HRG) assessment for clinical trial eligibility testing in a molecular registry (PRAEGNANT) in Germany. BMC Cancer. 2020 Nov 11; 20(1):1091.
-
Improving Stratification for Children With Late Bone Marrow B-Cell Acute Lymphoblastic Leukemia Relapses With Refined Response Classification and Integration of Genetics. J Clin Oncol. 2019 12 20; 37(36):3493-3506.
-
Metabolic Functions of Gut Microbes Associate With Efficacy of?Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. Gastroenterology. 2019 11; 157(5):1279-1292.e11.
-
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. Crit Rev Oncol Hematol. 2019 Feb; 134:39-45.
-
Computerized patient identification for the EMBRACA clinical trial using real-time data from the PRAEGNANT network for metastatic breast cancer patients. Breast Cancer Res Treat. 2016 07; 158(1):59-65.
-
Long-term independent predictors of positive response to cardiac resynchronization therapy. J Cardiovasc Med (Hagerstown). 2013 Apr; 14(4):301-7.
-
The Brustkrebs-Studien.de website for breast cancer patients: User acceptance of a German internet portal offering information on the disease and treatment options, and a clinical trials matching service. BMC Cancer. 2010 Dec 02; 10:663.
-
HER-2 gene amplification can be acquired as breast cancer progresses. Proc Natl Acad Sci U S A. 2004 Jun 22; 101(25):9393-8.